Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradation
- 9 December 1993
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 36 (12), 1709-1717
- https://doi.org/10.1002/art.1780361210
Abstract
Objective. To investigate mechanisms of cartilage matrix destruction by a study of the effects of a specific inactivator of cathepsin B and an inhibitor of several matrix metalloproteinases (MMP) on cartilage proteoglycan release. Methods. Cartilage explants were treated with either recombinant human interleukin‐1α (rHuIL‐1α) or retinoic acid in the presence or absence of the inhibitors, and proteoglycan release was quantitated. Tests for nonspecific effects of the inhibitors included reversibility, rates of protein synthesis and glycolysis, and effects on other rHuIL‐1α–mediated events. Results. The cathepsin B inactivator inhibited rHuIL‐1α–stimulated proteoglycan release at nanomolar concentrations, but failed to significantly inhibit retinoic acid–stimulated proteoglycan release. An inhibitor of MMP was inhibitory to both rHuIL‐1α–stimulated release and retinoic acid–stimulated release. Conclusion. Cathepsin B is implicated in rHuIL‐1α–stimulated loss of cartilage proteoglycan. Its lack of involvement in retinoic acid–stimulated proteoglycan release suggests the existence of at least 2 pathways of cartilage proteoglycan breakdown, which may converge at the activation of a matrix prometalloproteinase.Keywords
This publication has 34 references indexed in Scilit:
- A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilagein vitroInflammation Research, 1992
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivoFEBS Letters, 1991
- Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitroFEBS Letters, 1991
- Murine interleukin‐1 receptor: Differences in binding properties between fibroblastic and thymoma cells and evidence for a two‐chain receptor modelFEBS Letters, 1987
- Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blueBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64.Journal of Pharmacobio-Dynamics, 1986
- Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissuesNature, 1984
- THE IMMUNOCYTOCHEMICAL DEMONSTRATION OF CATHEPSIN DJournal of Histochemistry & Cytochemistry, 1972
- COMPARISON OF THE EFFECTS OF PAPAIN AND VITAMIN A ON CARTILAGEThe Journal of Experimental Medicine, 1960